Oral semaglutide vs DPP-4i on body weight in Japanese people with type 2 diabetes - Trial UMIN000051448

Name: Clinical Trial UMIN000051448
Creator: Dokkyo Medical University Department of Endocrinology and Metabolism
Keywords: Type 2 diabetes, drug, clinical trial, Japan

Access comprehensive clinical trial information for UMIN000051448 through Pure Global AI's free database. This phase not specified trial is sponsored by Dokkyo Medical University Department of Endocrinology and Metabolism and is currently Recruiting. The study focuses on Type 2 diabetes.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to University Hospital Medical Information Network data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database

840K+ Trials

UMIN000051448

Recruiting

drug

Trial Details

University Hospital Medical Information Network • UMIN000051448

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Oral semaglutide vs DPP-4i on body weight in Japanese people with type 2 diabetes

Study Focus

Disease/Condition

Type 2 diabetes

Study Type

Interventional

Intervention Type

drug

Sponsor & Location

Primary Sponsor

Dokkyo Medical University Department of Endocrinology and Metabolism

Location

Japan

Timeline & Enrollment

Phase

N/A

Start Date

May 23, 2022

End Date

N/A

ICD-10 Classifications

Type 2 diabetes mellitus

Type 2 diabetes mellitus without complications

Type 2 diabetes mellitus with unspecified complications

Type 2 diabetes mellitus with other specified complications

Type 2 diabetes mellitus with multiple complications

Data Source

Registry

University Hospital Medical Information Network

Trial ID

UMIN000051448

Type

Non-Device Trial